News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Alzheon Appoints Franz Hefti, PhD, To Board Of Directors



4/15/2014 6:41:16 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Alzheon, Inc., a clinical-stage biopharmaceutical company focused on brain health, memory and aging, announced today that it has appointed Franz F. Hefti, PhD, to the company’s Board of Directors. Dr. Hefti’s leadership and expertise in drug development for Alzheimer’s disease will support Alzheon’s continued growth and advancement as a leading clinical-stage Alzheimer’s company.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
Alzheon
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES